This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1998 Nov;2(11):869-76.

The dilemma of MDR-TB in the global era

P Farmer¹, J Bayona, M Becerra, J Furin, C Henry, H Hiatt, J Y Kim, C Mitnick, E Nardell, S Shin

Affiliations

PMID: 9848606

Comment

The dilemma of MDR-TB in the global era

P Farmer et al. Int J Tuberc Lung Dis. 1998 Nov.

. 1998 Nov;2(11):869-76.

Authors

P Farmer¹, J Bayona, M Becerra, J Furin, C Henry, H Hiatt, J Y Kim, C Mitnick, E Nardell, S Shin

Affiliation

¹ Department of Social Medicine, Harvard Medical School, Boston, MA 02115, USA.

PMID: 9848606

No abstract available

PubMed Disclaimer

Comment in

DOTS plus strategy in resource-poor countries.
Ollé-Goig JE. Ollé-Goig JE. Int J Tuberc Lung Dis. 1999 Sep;3(9):843; author reply 844. Int J Tuberc Lung Dis. 1999. PMID: 10488895 No abstract available.
DOTS plus strategy in resource-poor countries.
Davies PD. Davies PD. Int J Tuberc Lung Dis. 1999 Sep;3(9):843-4. Int J Tuberc Lung Dis. 1999. PMID: 10488896 No abstract available.

Comment on

MDR-TB and the developing world--a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy.
Iseman MD. Iseman MD. Int J Tuberc Lung Dis. 1998 Nov;2(11):867. Int J Tuberc Lung Dis. 1998. PMID: 9848604 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ingenta plc
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov